Step Therapy Criteria 2014 4 Tier Standard Last Updated: 10/22/2013
ANGIOTENSIN RECEPTOR BLOCKERS Products Affected
Criteria
Step 1: First line therapy should be losartan or losartan/hctz or valsartan/hctz. Step 2: Second line therapy should be Benicar, Benicar HCT, Edarbi or Edarbyclor. Step 3: Once losartan or losartan/hctz or valsartan/hctz and Benicar, Benicar HCT, Edarbi or Edarbyclor have been tried, patients can receive therapy with Diovan.
Products Affected
Criteria
Step 1: First line therapy should be selegiline tablets or capsules. Step 2: Once selegiline tablets or capsules have been tried, patients can receive therapy with Azilect.
CALCIUM CHANNEL BLOCKERS Products Affected
Criteria
Step 1: First line therapy should be felodipine or amlodipine. Step 2: Once felodipine or amlodipine have been tried, patients can receive therapy with nifedipine ER or isradipine.
COX-2 INHIBITORS Products Affected
Criteria
Step 1: First line therapy must be trial of 1 formulary non-selective NSAID. Step 2: Once one of these agents have been tried, patients can receive therapy with Celebrex.
Products Affected
Criteria
Step 1: First line therapy should be atorvastatin. Step 2: Once atorvastatin has been tried, patients can receive therapy with Crestor.
EPLERENONE Products Affected
Criteria
Step 1: First line therapy should be spironolactone or spironolactone/hctz. Step 2: Once spironolactone or spironolactone/hctz have been tried, patients can receive therapy with eplerenone.
HYPOGLYCEMICS Products Affected
Criteria
Step 1: First line therapy should be a formulary sulfonylurea, metformin, or formulary insulin (if appropriate). Step 2: Once one of these agents has been tried, patients can receive therapy with other formulary hypoglycemics such as Actoplus Met, Actoplus Met XR, Actos, Avandamet, Avandaryl, Avandia, Duetact, Acarbose, Januvia, Janumet, Janumet XR, Onglyza, Prandin, nateglinide, Kombiglyze XR, pioglitazone, pioglitazone/metformin, pioglitazone/glimepiride, Tradjenta, and Jentadueto.
OPHTHALMIC ANTIHISTAMINES Products Affected
Criteria
Step 1: First line therapy should be Zaditor OTC, ketotifen OTC or Alaway OTC. Step 2: Second line therapy should be Patanol or Pataday. Step 3: Once Patanol or Pataday has been tried, patients can receive therapy with other formulary prescription ophthalmic antihistamines such as Elestat, azelastine, epinastine, and Optivar.
PROTON PUMP INHIBITORS Products Affected
Criteria
Step 1: First line therapy should be Omeprazole or pantoprazole. Step 2: Second line should be lansoprazole or Dexilant. Step 3: Once omeprazole or pantoprazole and lansoprazole or Dexilant has been tried, patients can receive therapy with Nexium or Aciphex.
TOPICAL IMMUNOMODULATORS Products Affected
Criteria
Step 1: First line therapy should be trial of 2 formulary topical corticosteroids. Step 2: Once two of these agents have been tried, patients can receive therapy with Elidel or Protopic.
A I J K L B N C O D P E H T
Drugs Offer No Benefit in Curbing Aggression, Study Finds The drugs most widely used to manage aggressive outbursts in intellectually disabled people are no more effective than placebos for most patients and may be less so, researchers report. The finding, being published Friday, sharply challenges standard medical practice in clinics ain the United States and around the world. In recent ye
VNG TEST INSTRUCTIONS Appointment is at the Exton office . Date/Time____________________________________ Proceed directly to the Audiology waiting area. **PLEASE READ ALL INSTRUCTIONS AT LEAST 48 HOURS PRIOR TO TEST TO ENSURE INSTRUCTIONS ARE FOLLOWED PROPERLY. Failure to do so could result in cancellation and a $75 charge. If you are having multiple tests scheduled, THESE INSTRUCTIO